Professor Zhang Man investigates the Oncor biology

On the morning of August 31, Professor Zhang Man, former president of the Branch of Laboratory Physicians of the Chinese Medical Doctor Association, came to Onke Biomedical Technology (Suzhou) Co., Ltd. for investigation. Qian Ze, general manager of Onke Bio-led the technical backbone of the company to warmly receive Professor Zhang and his delegation. Professor Zhang has been engaged in tumor markers and urine proteomics related research and laboratory medicine for more than 20 years, and is a leader in urine detection research.

Zhang Man, Professor, Chief physician, supervisor of doctoral student and postdoctoral mobile station. Director of the Laboratory Center of Beijing Millennium Temple Hospital affiliated to Capital Medical University, established the standardized training system for laboratory physicians in China, the examination and diagnosis report system, and the five-level examination report model. The president of the World Chinese Association of Laboratory and Pathologist, the third chairman of the committee of the Chinese Medical Doctor Association Laboratory Physician Branch, undertook the national 863, 973, the Ministry of Science and Technology special, fund and other scientific research projects, published more than 100 articles, applied for 12 invention patents, edited 8 books, won 3 science and technology progress awards, provincial and ministerial science and technology achievement awards 1. Won the honorary title of "National Famous Doctor" in 2019.

Professor Zhang listened carefully to the development process, product layout and market situation of Aoke Biology. The company's innovative product - Prostatic body leakage protein test project was highly evaluated, believing that the company has created a new territory in prostate disease detection, and affirmed the long-term vision and perspective of the leadership.

Professor Zhang has been committed to the study and application of urine proteomics for many years. Professor Zhang believes that the convenience of urine samples and the richness of metabolic types make urine have great potential for scientific research and clinical application. This is also consistent with the corporate philosophy of Oncor Biology to build a globally unique urine innovative disease diagnosis platform.

Professor Zhang focuses on the continuous progress and innovation of clinical laboratory science in China, and hopes to jointly innovate with enterprises with pioneering spirit such as Angke Biology, relying on the advantages of the expert group of colleges, schools and enterprises to build China's own IVD product characteristic brand. In this exchange, Professor Zhang and Anco Biology reached a consensus to promote the urine sample testing committee, relying on the platform of the committee, the two sides will later establish a huge urine sample storage library, innovative development of new technologies based on urine detection of diseases, and establish a new industry standard for urine sample testing projects, but also the implementation of talent exchange and joint training in the industry.

Professor Zhang then visited the company's laboratory and GMP workshop; It is believed that the company can exceed the industry standard to build laboratories and production workshops with higher requirements and higher standards, which is a long-term vision. The company has given guiding opinions on the research and development and market development of the company, and wishes the development of Aoke Biology is getting better and better.